Anemia Panel
Anemia is a condition characterized by decreased red blood cell mass or hemoglobin, resulting in reduced oxygen-carrying capacity. The anemia panel is a comprehensive set of laboratory tests used to evaluate the presence, severity, and underlying cause of anemia. It integrates hematologic, biochemical, and iron metabolism markers to support accurate diagnosis and guide management.
The panel typically includes a complete blood count (CBC) with red blood cell indices, reticulocyte count, iron studies, ferritin, and additional tests such as folate and erythropoietin when clinically indicated. The CBC provides initial classification of anemia based on red blood cell size and hemoglobin content, while the reticulocyte count assesses bone marrow response.
Iron studies and ferritin evaluate iron status and help distinguish iron deficiency from anemia of chronic disease or iron overload. Folate testing supports identification of macrocytic anemia, and erythropoietin levels may aid in evaluating anemia related to renal disease or bone marrow disorders. Additional specialized tests, including genetic testing for hereditary hemochromatosis or urine hemosiderin, may be used in selected cases.
This integrated approach allows differentiation between production defects, increased destruction, or blood loss, and supports targeted diagnostic and therapeutic decisions.
- Evaluation and classification of anemia (microcytic, normocytic, macrocytic)
- Differentiation of iron deficiency anemia, anemia of chronic disease, and iron overload states
- Assessment of bone marrow response using reticulocyte count
- Identification of nutritional deficiencies (iron, folate) contributing to anemia
- Evaluation of anemia related to chronic kidney disease or systemic illness
- Adjunctive assessment for hemolysis, hereditary disorders, and metabolic causes of anemia
- Abnormal CBC parameters (hemoglobin, hematocrit, RBC indices) indicate anemia and help classify its type.
- Low reticulocyte count suggests decreased production (e.g., iron deficiency, marrow suppression), while elevated levels suggest increased destruction or blood loss.
- Iron deficiency is characterized by low serum iron, low ferritin, high TIBC, and low transferrin saturation.
- Anemia of chronic disease typically shows low serum iron with normal or elevated ferritin and low or normal TIBC.
- Elevated ferritin may indicate inflammation, chronic disease, or iron overload.
- Low folate levels are associated with macrocytic (megaloblastic) anemia.
- Erythropoietin levels are decreased in chronic kidney disease and may be elevated in hypoxic or hemolytic states.
- Clinical interpretation should consider patient history, comorbid conditions, and additional laboratory findings.
CBC:
WBC: 4.0–11.0 K/µL
RBC: Male 3.9–5.9 M/µL; Female 3.7–5.4 M/µL
Hemoglobin: Male 13.0–17.3 g/dL; Female 11.4–15.4 g/dL
Hematocrit: Male 39–53%; Female 35–47%
MCV: 81–100 fL
Ferritin:
Male: 24–336 ng/mL
Female: 11–307 ng/mL
Iron: 50–175 µg/dL
TIBC: 250–460 µg/dL
Reticulocyte: 0.5–1.5% (adults)
Vitamin B12: 250-1100 pg/mL (185-812 pmol/L)
Folic Acid: 4.2-19.9 ng/mL (9.5 – 45.2 nmol/L)
Automated hematology analyzers for CBC and reticulocyte count.
Spectrophotometric and immunoassay methods for iron studies and ferritin.
Immunoassay methods for folate and erythropoietin.
Molecular methods for genetic testing when indicated.
Whole blood (EDTA) for CBC and reticulocyte count.
Serum or plasma for iron studies, ferritin, folate, and erythropoietin.
Urine specimen for hemosiderin testing when indicated.
Vitamin B12, Peripheral blood smear, Lactate dehydrogenase (LDH), Haptoglobin, Direct antiglobulin test (Coombs), Hemoglobin electrophoresis
Bone marrow evaluation (when indicated).
1-3 days
- Hematol. 2005;11(2):83-90. [PMID:16024331]
- Lab Hematol. 2005;11:285. [PMID:16475476]
- Mayo Clin Proc. 2005;80:923. [PMID:16007898]
- Arch Pathol Lab Med. 2006;130:596. [PMID:16683868]
- N Engl J Med. 2005 Mar 10;352(10):1011-23. [PMID:15758012]
- Am Fam Physician. 2002;65:853.[PMID:11898957]
- Am J Clin Pathol. 2002;117:871. [PMID:12047138]
- Am J Med. 2001 Feb 1;110(2):88-90. [PMID:11165548]
- Ann Intern Med. 2005;143:522. [PMID:16204165]
- Biochim Biophys Acta. 1996 Jul 31;1275(3):161-203. [PMID:8695634]
- Biofactors. 1988 Oct;1(3):207-12. [PMID:3076774]
- Blood Rev. 1989 Jun;3(2):130-5. [PMID:2673445]
- Blood Rev. 2006;20:299. [PMID:16716475]
- Clin Chem Lab Med. 2002 Oct;40(10):1014-8. [PMID:12476940]
- Clin Chem. 2002 Sep;48(9):1565-70. [PMID:12194935]
- Clin Chem. 2003 Jan;49(1):175-8. [PMID:12507977]
- Hematol Oncol Clin North Am. 1989 Sep;3(3):369-400. [PMID:2561121]
- Hematol Oncol Clin North Am. 2002;16:373. [PMID:12094477]
- Hematology. 2006 Jun;11(3):183-6. [PMID:17325959]
- Int J Clin Lab Res. 1998;28(1):1-11. [PMID:9594357]
- Int Rev Exp Pathol. 1980;22:193-225. [PMID:7005144]
- J Vasc Surg. 2003;37:132. [PMID:12514590]
- Kidney Int Suppl. 2006;101:S4.†[PMID:16830699]
- Mayo Clin Proc. 2006;81:1188. [PMID:16970215]
- N Engl J Med. 2005;352:1011. [PMID:15758012]
- Transfus Clin Biol. 2001 Oct;8(5):422-32. [PMID:11729396]
- World J Gastroenterol. 2009 Oct 7;15(37):4644-52. [PMID:19787827]
- Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
- Mazza, Joseph J. (2002). Manual of Clinical Hematology. 3rd. Philadelphia. Lippincott Williams & Wilkins.
- McClatchey, Kenneth D. (2002). Clinical Laboratory Medicine. 2nd. Philadelphia. Lippincott Williams & Wilkins.
- McPherson R, Pincus M (eds). Henry’s Clinical Diagnosis and Management by Laboratory Methods. 21st ed. Philadelphia, PA: Saunders Elsevier. (2007), p. 147.